Quest Diagnostics Inc
Gesloten
SectorGezondheidszorg
193.88 -2.04
Overzicht
Wijziging aandelenprijs
24u
Min
193.27
Max
194.96
Inkomsten | 19M 264M |
|---|---|
Verkoop | 89M 2.9B |
K/W Sectorgemiddelde | 22.316 49.712 |
EPS | 2.5 |
Dividendrendement | 1.61 |
Winstmarge | 9.119 |
Werknemers | 57,000 |
EBITDA | 33M 434M |
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | +14.43% upside |
Dividendrendement Sectorgemiddelde | 1.61% 2.36% |
|---|---|
Volgende Winsten | 23 jul 2026 |
Volgende dividenddatum | 22 jul 2026 |
Volgende Ex Dividend datum | 8 jul 2026 |
Marktkapitalisatie | 652M 22B |
|---|---|
Vorige openingsprijs | 195.92 |
Vorige sluitingsprijs | 193.88 |
Nieuwssentiment
By Acuity
50%
50%
123 / 342 Rangschikking in Healthcare
Quest Diagnostics Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.